Orecchioni, S.; Falvo, P.; Talarico, G.; Mitola, G.; Bravetti, G.; Mancuso, P.; Nicoli, P.; Bertolini, F.
Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge. J. Clin. Med. 2023, 12, 2535.
https://doi.org/10.3390/jcm12072535
AMA Style
Orecchioni S, Falvo P, Talarico G, Mitola G, Bravetti G, Mancuso P, Nicoli P, Bertolini F.
Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge. Journal of Clinical Medicine. 2023; 12(7):2535.
https://doi.org/10.3390/jcm12072535
Chicago/Turabian Style
Orecchioni, Stefania, Paolo Falvo, Giovanna Talarico, Giulia Mitola, Giulia Bravetti, Patrizia Mancuso, Paola Nicoli, and Francesco Bertolini.
2023. "Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge" Journal of Clinical Medicine 12, no. 7: 2535.
https://doi.org/10.3390/jcm12072535
APA Style
Orecchioni, S., Falvo, P., Talarico, G., Mitola, G., Bravetti, G., Mancuso, P., Nicoli, P., & Bertolini, F.
(2023). Vinorelbine and Intermittent Cyclophosphamide Sensitize an Aggressive Myc-Driven B-Cell Lymphoma to Anti-PD-1 by an Immunological Memory Effective against Tumor Re-Challenge. Journal of Clinical Medicine, 12(7), 2535.
https://doi.org/10.3390/jcm12072535